ADMA
Adma Biologics, Inc.Company with tickers: ADMA
Market Cap
$2.02B
Shares Outstanding
231,772,715
CIK
1368514
CUSIP
000899104
13F Activity (30d)
4 filings
3 filers
Website
Visit website
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$500,000,000
as of 2025-05-31
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-03-31 YTD | $130,191,000 | 10-Q, filed 2026-05-06 |
| 2025-12-31 | $31,940,000 | 10-K, filed 2026-02-25 |
| 2024-12-31 | $0 | 10-K, filed 2026-02-25 |
| 2023-12-31 | $0 | 10-K, filed 2026-02-25 |
| 2012-12-31 | $150,000 | 10-K, filed 2014-03-28 |
| 2011-12-31 | $0 | 10-K, filed 2013-03-06 |